Kidney Cancer Book #1 Best Seller Status on Amazon.com
13 6월 2013 - 11:00PM
OTC Markets
KIDNEY
CANCER BOOK ACHIEVES NUMBER 1
BEST SELLER STATUS ON AMAZON.COM
STOCKTON, CALIFORNIA/June 13, 2013 /
Newswire/ -- Viratech Corp. (OTC:VIRA) announced today that
Cancer.im?s 7th book of 235
books slated to be released on Amazon?s Kindle platform,
focusing on Cancer, has achieved number 1 best-seller status for
Oncology.
The book,
Find & Stop Kidney Cancer by Dr.
Kevin Buckman and Cancer Patient Advocate Chris Ryan, has achieved
number 1
best-seller status for Oncology. The first book, Find and Stop
Breast
Cancer, became a best seller earlier this year after only
three days. The
book Find & Stop Kidney Cancer
can be bought here: http://www.amazon.com/Kidney-Cancer-Find-Stop-ebook/dp/B00D7V5HBQ/ref=sr_1_1?s=books&ie=UTF8&qid=1370883969&sr=1-1&keywords=kidney+cancer+find+and+stop
Dr Buckman,
states, ?All too often Kidney cancer is found at late stages, since
it can be
hidden with little or no symptoms. This
book is meant to raise awareness about kidney cancer, and also
about cancer in
general, and how important that early detection and treatment
is. We dedicated this to a local friend who has
kidney cancer spread throughout his body.
He is only 22 years old.?
The different types of kidney cancer develop
in different ways, meaning that the diseases have different
outlooks (or
prognosis), and need to be staged and treated in different ways.
The most
common signs and symptoms of kidney cancer are a lump in the
abdomen and/or
blood in the urine (or hematuria). Other symptoms may include
tiredness, loss
of appetite, weight loss, a high temperature and heavy sweating,
and persistent
pain in the abdomen. However, many of
these symptoms can be caused by other conditions, and there may
also be no
signs or symptoms in a person with kidney cancer, especially in the
early stages
of the disease.
Cancer is a diverse class of diseases
which differ widely in their causes and biology. Any organism can
acquire
cancer. Nearly all known cancers arise gradually, as errors build
up in the
cancer cell, and its progeny and cancer cells can be found in our
bodies since
childhood and increase with age and exposure to
carcinogens.
According to the book, ?Cancer.im
(www.cancer.im) is working to find new screening tests for cancer
and new modes
of therapy. The site, which launched on February 15, 2013, includes
a user
friendly Mission Adaptive Plan (a MAP) that can be tailored for
each user, and
15 modules for dealing with the disease, which are based on the
Robert Ryan
Cancer Protocol. Based on more than 19 medical studies on
quality of life and
associated longevity, following the Robert Ryan Cancer
Protocol
decreases the morbidity of cancer by increasing the quality of life
by the use
of these 15 steps which allows a cancer patient to be
proactive. There is
no charge for this service.? An explanatory video of the power of a
Cancer
Support Social Network can be seen here:
http://www.youtube.com/watch?v=dz1tHRb3wvU
About Cancer.im
Through its experience-based
search engine and technology, Cancer.im's goal is to become the
primary
resource on the web for people affected by cancer, for the purpose
of making a
difference in their own lives and the lives of others.
Cancer.im?s
mission is to empower every cancer patient with the ability to
research their
disease and to find, organize, and manage their own cancer support
network at
no charge to them. The goal of these support networks is to assist
the patient
in conserving needed energy by reducing the burden associated with
their own
daily trials and tribulations. Cancer.im will strive to convert
this saved
energy into a higher level of patient activity and a stronger
determination to
fight their disease.
In addition Cancer.im is seeking
new cancer researchers who wish to leverage its intellectual
property and
social network platform for the purpose of creating new
distribution and
engagement channels.
About Viratech Corp.
Viratech
Corp. has created the
first open source biotech research social network platform. The
purpose of the platform
is to make it possible for individuals or smaller companies to
compete with
larger companies in the race to patent new medicines or technology.
This has
been made possible by leveraging social collaboration in a way that
allows new
biotech ventures the ability to protect their intellectual
property, then
simultaneously allowing those same ventures the ability to promote
and
crowdsource their development.
Contact: Kevin
Buckman MD
Viratech, Corp.
http://viratech.org
Email Contact: info@viratech.org
209-477-3030
Viratech (PK) (USOTC:VIRA)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Viratech (PK) (USOTC:VIRA)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024